Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB600-584 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB600-584, RRID:AB_10132036
- Product name
- Rabbit Monoclonal Cyclin D1 Antibody
- Antibody type
- Monoclonal
- Antigen
- Synthetic peptide from C-terminus of human cyclin D1 (within amino acids 250-295 of P24385 - UniProt).
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Antigen sequence
C-terminus- Vial size
- 0.1 ml
- Storage
- Store at 4C. Do not freeze.
Submitted references SOX3 promotes generation of committed spermatogonia in postnatal mouse testes.
DDX5 plays essential transcriptional and post-transcriptional roles in the maintenance and function of spermatogonia.
Hormetic dose response to (L)-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression.
p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors.
Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.
Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody.
Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody.
McAninch D, Mäkelä JA, La HM, Hughes JN, Lovell-Badge R, Hobbs RM, Thomas PQ
Scientific reports 2020 Apr 21;10(1):6751
Scientific reports 2020 Apr 21;10(1):6751
DDX5 plays essential transcriptional and post-transcriptional roles in the maintenance and function of spermatogonia.
Legrand JMD, Chan AL, La HM, Rossello FJ, Änkö ML, Fuller-Pace FV, Hobbs RM
Nature communications 2019 May 23;10(1):2278
Nature communications 2019 May 23;10(1):2278
Hormetic dose response to (L)-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression.
Cho S, Chae JS, Shin H, Shin Y, Song H, Kim Y, Yoo BC, Roh K, Cho S, Kil EJ, Byun HS, Cho SH, Park S, Lee S, Yeom CH
Scientific reports 2018 Jul 27;8(1):11372
Scientific reports 2018 Jul 27;8(1):11372
p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors.
Kuo WL, Sharifi MN, Lingen MW, Ahmed O, Liu J, Nagilla M, Macleod KF, Cohen EE
PloS one 2014;9(3):e90171
PloS one 2014;9(3):e90171
Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.
Kuo WL, Liu J, Mauceri H, Vokes EE, Weichselbaum R, Rosner MR, Cohen EE
Molecular cancer therapeutics 2010 Oct;9(10):2814-24
Molecular cancer therapeutics 2010 Oct;9(10):2814-24
Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody.
Cheuk W, Wong KO, Wong CS, Chan JK
The American journal of surgical pathology 2004 Jun;28(6):801-7
The American journal of surgical pathology 2004 Jun;28(6):801-7
Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody.
Cheuk W, Wong KO, Wong CS, Chan JK
The American journal of surgical pathology 2004 Jun;28(6):801-7
The American journal of surgical pathology 2004 Jun;28(6):801-7
No comments: Submit comment
No validations: Submit validation data